Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseTBIControlled cortical impactC57BL/6J; CX3CR1-GFP (B6.129P-Cx3cr1tm1Litt/J) for two-photon microglial imagingMalen = n = 4 per condition for hydrogen peroxide assay; n = 3 mice…Intravenous, by retro-orbital injection100 ug anti-ICAM-1/catalase conjugate per mouse; comparator…30 min after controlled cortical impact
Model: Moderate controlled cortical impact traumatic brain injury: 4 mm craniectomy over right somatosensory cortex, impact at 3.5 m/s to 1 mm depth with a 2 mm piston and 0.5 s dwell time
Targeted anti-ICAM-1/catalase given 30 min post-impact normalised cortical hydrogen peroxide, cut 3-nitrotyrosine, preserved blood-brain barrier integrity and tight junction proteins, and reduced neuronal loss, astrogliosis and microglial activation. Non-targeted catalase or anti-ICAM-1 antibody al…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.